ClinicalTrials.Veeva

Menu

Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure

T

Tanta University

Status

Invitation-only

Conditions

Osteomyelitis of Jaw

Treatments

Device: management of medication related osteonecrosis of the jaw

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

20 patients with MRONJ underwent surgical debridement using piezosurgery then closure using double periosteal flap

Full description

20 patients with MRONJ underwent surgical debridement, crestal incision and oblique releasing incision were performed to expose the area of osteomyelitis, then squesterum was removed using piezosurgery. After complete debridement, the periosteal layer was dissected from mucoperiosteal buccal flap and based superiorly, then turn upward to be sutured to the lingual flap followed by suturing of buccal flap to achieve double layers closure

Enrollment

20 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients with MRONJ

Exclusion criteria

  • patients had a history of radiotherapy Patients need only conservative treatment

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

management of medication related osteonecrosis of the jaw
Experimental group
Description:
The buccal mucoperiosteal flap was elevated to expose the area of osteonecrosis in the mandible. it was debrided using piezosurgery then closure was achieved using double periosteal flap
Treatment:
Device: management of medication related osteonecrosis of the jaw

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems